By using in vitro melanoma and monocyte cells and two different in vivo models, i.e., mouse and zebrafish, in this study we demonstrated that melanoma-specific Bcl-xL promotes the recruitment of macrophages at the tumor site and induces a pro-tumoral M2 phenotype, though the release of soluble factors. Here, BCL2L1 is linked to melanoma.